Viewing Study NCT03426592



Ignite Creation Date: 2024-05-06 @ 11:05 AM
Last Modification Date: 2024-10-26 @ 12:40 PM
Study NCT ID: NCT03426592
Status: COMPLETED
Last Update Posted: 2019-06-05
First Post: 2018-02-01

Brief Title: Effect of High Dose Vitamin D Supplementation on HIV Latency
Sponsor: University of Melbourne
Organization: University of Melbourne

Study Overview

Official Title: Effect of High Dose Vitamin D Supplementation on HIV Latency A Pilot Randomized Controlled Trial
Status: COMPLETED
Status Verified Date: 2019-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: VIVA
Brief Summary: HIV persists despite antiretroviral therapy ART and is associated with chronic inflammation This inflammation is thought to prevent an effective immune response against the virus and is mediated at least in part by gut epithelial permeability and microbial translocation HIV accumulates preferentially within Th17 cells with time on ART these memory CD4 T cells are highly susceptible to HIV infection and are concentrated within the gut Vitamin D promotes gut epithelial integrity in animal models and exerts anti-inflammatory effects on the human immune system including down-modulation of Th17 cell frequency This study will evaluate whether high dose vitamin D is able to reduce immune activation and Th17 cell frequency to improve gut barrier integrity and the gut microbiome and reduce HIV persistence in participants on long-term suppressive ART
Detailed Description: The major barrier to a cure for HIV infection is the persistence of latently infected CD4 T cells on antiretroviral therapy ART HIV is concentrated in vivo in Th17 cells in blood and the gastrointestinal tract Th17 cells are critical mediators of mucosal immunity against bacteria and fungi and are rapidly depleted in the gut following HIV acquisition with subsequent gut epithelial permeability microbial translocation and ensuing chronic inflammation which is not completely reversed on ART Such inflammation may contribute to HIV persistence by potentiating T cell proliferation and thereby clonal expansion of infected cells by exacerbating CD8 T cell exhaustion and potentially by promoting viral replication despite ART

Vitamin D has pleiotropic effects on the immune system including directing naïve CD4 T cells away from the Th17 phenotype toward an anti-inflammatory regulatory T cell phenotype It may also have beneficial effects on dendritic cell and CD8 T cell immunity Furthermore vitamin D has been shown in animal models to strengthen gut epithelial integrity and in healthy volunteers to promote a more diverse gut microbiome

The investigators plan to perform a pilot randomized double-blind placebo-controlled trial of high dose vitamin D supplementation in HIV-infected participants on suppressive ART and to determine its effect on immune activation Th17 cell frequency gut barrier integrity the gut microbiome and HIV persistence

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None